Logo image
Identification and characterization of a novel class of atypical dopamine receptor agonists
Journal article   Peer reviewed

Identification and characterization of a novel class of atypical dopamine receptor agonists

E V Kuzhikandathil and S Kortagere
Pharmaceutical research, v 29(8), pp 2264-2275
Aug 2012
PMID: 22547031

Abstract

Cell Line Dopamine Agonists - pharmacology Receptors, Dopamine - metabolism Humans Butylamines - chemistry Models, Molecular Drug Discovery Receptors, Dopamine - chemistry Butylamines - metabolism Animals Protein Conformation Mice Dopamine Agonists - chemistry
The D3 dopamine receptor exhibits tolerance and slow response termination (SRT) properties that are not exhibited by the closely-related D2 dopamine receptor. We previously demonstrated that the induction of tolerance elicits a unique conformational change in the D3 receptor. Here we tested the hypothesis that the tolerance and SRT properties of the D3 receptor are ligand-dependent. We used pharmacophore modeling and in silico screening approaches coupled with electrophysiological and biochemical methods to identify and functionally characterize the novel dopamine receptor agonists. We identified cis-8-OH-PBZI (PBZI), FAUC73 and an additional novel compound, ES609, which although they are full D3 receptor agonists, do not induce the tolerance and SRT properties of the D3 receptor. In addition, PBZI has full intrinsic activity at D2L, is a partial agonist at D2S and exhibits functional selectivity at D4.2 dopamine receptors. ES609 is a partial agonist at D2S, D2L and D4.2 receptors, and exhibits functional selectivity at D2L and D4.2 dopamine receptors. We have discovered a novel class of atypical dopamine receptor agonists that include three structurally dissimilar compounds. These new agonists will help determine the physiological and pathophysiological relevance of D3 receptor tolerance and SRT properties.

Metrics

7 Record Views
18 citations in Scopus

Details

UN Sustainable Development Goals (SDGs)

This publication has contributed to the advancement of the following goals:

#3 Good Health and Well-Being

InCites Highlights

Data related to this publication, from InCites Benchmarking & Analytics tool:

Collaboration types
Domestic collaboration
Web of Science research areas
Chemistry, Multidisciplinary
Pharmacology & Pharmacy
Logo image